Paul B Gilman

Lankenau Institute For Medical Research

$5,012,402

Attributed

$5,012,402

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $541.3K · FY2005–11

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

Funding mix

By agency

NIH$5,012,402 · 1

By mechanism

U10$5,012,402 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Cancer Prevention”

David Heimbrook · Leidos Biomedical Research, Inc.$420,583,638
Larry Arthur$262,753,401
Norman Wolmark · Nsabp Foundation, Inc.$207,559,301
Charles A Coltman · Southwest Oncology Group$197,310,355
Philip J Disaia · University Of California Irvine$169,589,114
Gregory H Reaman · National Childhood Cancer Foundation$156,311,017

Research focus

Cancer PreventionClinical TrialsOncologyBehavioral /Social Science Research TagNeoplasm /Cancer TherapyCancer Rehabilitation /CareCommunitiesCooperative StudyCountyClinical ResearchCommunity Clinical Oncology ProgramColon CarcinomaCancer CareAwarenessAreaCommunity Health ServicesCancer GeneticsAdministratorCancer EtiologyCancer Prevention TrialCancer ControlBaseCatchment AreaCessation Of Life